CVS Plans a Breakup and a New Valuation Test for Shareholders

CVS Health plans to separate its retail pharmacies from its insurance and pharmacy-benefit operations. The proposed breakup gives investors a new question: can two focused businesses create more value than the combined group?

CVS Health spent years bringing pharmacies, insurance and healthcare services together. It now plans to separate major parts of that business.

The company announced plans to create two publicly traded companies, separating retail pharmacy operations from its Aetna insurance and Caremark pharmacy-benefit businesses. The separation is expected in early 2028, with existing shareholders retaining ownership in both companies.

The announcement turns CVS into a restructuring story as well as an earnings story.

Separating businesses can make their financial performance easier to evaluate. Investors can assign different valuations to operations with different growth prospects, capital needs and risks.

However, a breakup does not automatically create value. The outcome depends on the businesses’ earnings power, the cost of separation and how debt and shared expenses are allocated.

Those details will be central to assessing the proposed transaction. Investors will need to understand whether each company can fund investment, service its obligations and support shareholder returns independently.

The operating backdrop also matters. CVS reported third-quarter revenue of $108.4 billion, up 5.4%, and adjusted earnings of $2.09 per share, compared with $1.60 a year earlier. Its insurance segment showed improved profitability, although management remained cautious about elevated cost trends.

The proposed separation therefore arrives alongside improving results. Shareholders must assess both developments without assuming one guarantees the success of the other.

Between now and completion, execution remains important. Management must prepare the transaction while maintaining performance across the existing business.

Investor Take: The breakup could give investors a clearer view of CVS’s individual operations, but the financial terms will determine its value. Watch debt allocation, separation expenses and the earnings outlook for each company. Two listings create a different ownership structure; stronger cash generation is what would make that structure more valuable.

Category: Markets & InvestingTags: CVS Health, CVS, Corporate Breakup, Aetna, Caremark, Shareholder Value